Drug Information Association Logo

FDA Information Days Developed for Information Technology, Regulatory Affairs and Clinical Research Professionals

Horsham, PA, USA — Mar 1, 2012

DIA, in collaboration with FDA, is organizing back-to-back FDA Information Days in Silver Spring, MD. 

FDA Information Day: Individual Case Safety Reports (ICSR), held March 13-14, will explore the progress made in developing a new ICSR format by the International Conference on Harmonization (ICH) in collaboration with Standards Development Organizations.  .
FDA Information Day: Identification of Medicinal Products (IDMP), held March 14-15, will focus on the IDMP standards, which were developed in response to a worldwide demand for internationally harmonized specifications for exchanging medicinal product information in a robust and reliable manner. The IDMP standards support the regulation of medicines and pharmacovigilance including ICSR.

Session topics will include:

  • The ongoing international standardization work on ICSR and IDMP
  • New features of the ICSR and IDMP standards
  • Implementation of the new ICSR and IDMP standards for adaptation in pharmacovigilance systems

“ICH recently agreed to use the International Organization for Standardization (ISO) ICSR standard to meet the reporting requirements for E2B(R3). ICH defines the way that this standard should be used by means of the ICH Implementation Guide (IG), which covers the use of the fields defined by the E2B(R3),” said Program Chair Vada Perkins, MSc, BSN, RN, Regulatory Program Management Officer, Office of the Director, CBER, FDA. The ICH Implementation Guide has been further developed and reached Step 2 in June 2011. This guide has been released for ICH Step 3 public consultation.”

Register for both meetings and save $200!





ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.

Christine Tarlecki